J&J Drops Alligator’s MAb ADC-1013 After Reviewing Combination Data
Executive Summary
The anti-CD40 antibody underperformed in some preclinical cancer combination studies, leading J&J to prioritize other assets. Alligator Bioscience will now advance ADC-1013 while seeking a new partner.
You may also be interested in...
RFID Tags Found To Improve Drug Supply Chain Tracking In Recent DSCSA Pilot
A pilot that used RFID tags with 2D barcodes was touted as more effective than using 2D barcodes alone in tracking drugs through the supply chain.
Emergency Clinical Trial Guidance Offers A Peak At The Future Of Virtual Trials: Expert
The current pandemic has accelerated the US FDA’s perspective on conducting remote clinical trials. The agency has published an emergency guidance to allow sponsors to continue their work, which a former FDA official says is an indication of where the agency is headed post-COVID-19.
Umbrella EUA Authorizes Surgical Masks As COVID-19 PPE
Facing ongoing shortages, the US FDA is allowing most surgical masks to be used as personal protective equipment under a new emergency use authorization.
Need a specific report? 1000+ reports available
Buy Reports